Lindahl acts as legal advisor when Swedencare AB (publ) acquires the UK based company Custom Vet Products Ltd (CVP). The purchase price consists of a cash amount and an issue in kind of 620,095 shares in Swedencare to the selling member of management with payment as contribution of kind through transfer of units in the target corporation. Closing of the transaction occurred on 1 November 2022.
CVP is a manufacturer of high-quality veterinary products and supplements, such as pet soft chew products primarily sold in the UK and some European countries.
Swedencare develops, produces, markets and sells premium products in the global and fast-growing market for animal health products for cats, dogs and horses. Swedencare’s product groups are represented on approximately fifty markets around the world and are sold through subsidiaries in the Nordics, Italy, France, Spain, Greece, Ireland, United Kingdom and United States, and through an external distribution network. Swedencare’s shares are listed on Nasdaq First North Growth Market. Through the acquisition of CVP, Swedencare gains a strong position within the manufacturing and development of premium soft chews for the pet health market in United Kingdom and Europe.
Lindahl’s team consisted primarily of Johan Herrström, Annika Brandt, Max Stenberg and Erik Kronholm. Lindahl worked on the acquisition together with RPC (Reynolds Porter Chamberlain LLP) in England, a member of the same global network as Lindahl, TerraLex.
